Asset Comparison and Correlation
|Abbott Laboratories vs BristolMyers Squibb Company|
Considering 30-days investment horizon, Abbott is expected to generate 4.39 times less return on investment than BristolMyers. But when comparing it to its historical volatility, Abbott Laboratories is 1.52 times less risky than BristolMyers. It trades about 0.14 of its potential returns per unit of risk. BristolMyers Squibb Company is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 3,991 in BristolMyers Squibb Company on April 26, 2013 and sell it today you would earn a total of 749 from holding BristolMyers Squibb Company or generate 18.77% return on investment over 30 days.
93% of all equities and portfolios perform better than Abbott Laboratories. Compared with the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 7 (%) of all global equities and portfolios over the last 30 days.
Match-ups for Abbott
78% of all equities and portfolios perform better than BristolMyers Squibb Company. Compared with the overall equity markets, risk-adjusted returns on investments in BristolMyers Squibb Company are ranked lower than 22 (%) of all global equities and portfolios over the last 30 days.
Match-ups for BristolMyers